AU2006206525A1 - Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases - Google Patents

Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases Download PDF

Info

Publication number
AU2006206525A1
AU2006206525A1 AU2006206525A AU2006206525A AU2006206525A1 AU 2006206525 A1 AU2006206525 A1 AU 2006206525A1 AU 2006206525 A AU2006206525 A AU 2006206525A AU 2006206525 A AU2006206525 A AU 2006206525A AU 2006206525 A1 AU2006206525 A1 AU 2006206525A1
Authority
AU
Australia
Prior art keywords
compound
pct
optionally substituted
mmol
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006206525A
Other languages
English (en)
Other versions
AU2006206525A2 (en
Inventor
Laurence Burgess
John Gaudino
Kevin Hunt
Stephen Schlachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Array Biopharma Inc
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Publication of AU2006206525A2 publication Critical patent/AU2006206525A2/en
Publication of AU2006206525A1 publication Critical patent/AU2006206525A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2006206525A 2005-01-20 2006-01-19 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases Abandoned AU2006206525A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64555205P 2005-01-20 2005-01-20
US60/645,552 2005-01-20
PCT/US2006/001747 WO2006078724A2 (en) 2005-01-20 2006-01-19 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases

Publications (2)

Publication Number Publication Date
AU2006206525A2 AU2006206525A2 (en) 2006-07-27
AU2006206525A1 true AU2006206525A1 (en) 2006-07-27

Family

ID=36692822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006206525A Abandoned AU2006206525A1 (en) 2005-01-20 2006-01-19 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases

Country Status (8)

Country Link
US (1) US7553842B2 (cg-RX-API-DMAC10.html)
EP (1) EP1838316A4 (cg-RX-API-DMAC10.html)
JP (1) JP2008528491A (cg-RX-API-DMAC10.html)
AU (1) AU2006206525A1 (cg-RX-API-DMAC10.html)
CA (1) CA2601380A1 (cg-RX-API-DMAC10.html)
MX (1) MX2007008662A (cg-RX-API-DMAC10.html)
TW (1) TW200637552A (cg-RX-API-DMAC10.html)
WO (1) WO2006078724A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904540D0 (en) * 2009-03-17 2009-04-29 Biotica Tech Ltd Novel compounds and methods for their production
GB0917817D0 (en) * 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
GB0917816D0 (en) * 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
IT1401451B1 (it) * 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
US9814703B2 (en) 2013-11-14 2017-11-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of BMP signaling
EP3433259B1 (en) * 2016-03-24 2021-06-30 The Administrators of The Tulane Educational Fund Conjugates of tacrolimus, their compositions, and their uses
CA3043575A1 (en) * 2016-11-10 2018-05-17 Novartis Ag Bmp potentiators
CN108148032B (zh) * 2018-03-01 2019-12-13 北京海步医药科技股份有限公司 一种3,4-二氢-2h-1-苯并吡喃-2-羧酸类化合物的制备方法及其应用
CN119751235A (zh) * 2019-01-23 2025-04-04 约翰霍普金斯大学 非免疫抑制性fk506类似物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2245891A (en) 1990-07-09 1992-01-15 Fujisawa Pharmaceutical Co Tricyclo compounds
US5565560A (en) 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5457111A (en) * 1991-09-05 1995-10-10 Abbott Laboratories Macrocyclic immunomodulators
US5563172A (en) * 1991-09-05 1996-10-08 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5284877A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkyl and alkenyl macrolides having immunosuppressive activity
WO1994021634A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
WO1994021254A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Substituted alicyclic amine-containing macrocyclic immunomodulators
WO1994021642A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US6093615A (en) * 1994-08-15 2000-07-25 Micron Technology, Inc. Method of fabricating a contact structure having a composite barrier layer between a platinum layer and a polysilicon plug
DE19859467C2 (de) * 1998-12-22 2002-11-28 Steag Micro Tech Gmbh Substrathalter
US6569867B2 (en) * 1999-10-01 2003-05-27 Kosan Biosciences, Inc. Polyketide derivatives

Also Published As

Publication number Publication date
AU2006206525A2 (en) 2006-07-27
TW200637552A (en) 2006-11-01
EP1838316A4 (en) 2012-01-25
WO2006078724A3 (en) 2008-01-24
US20060160838A1 (en) 2006-07-20
EP1838316A2 (en) 2007-10-03
US7553842B2 (en) 2009-06-30
JP2008528491A (ja) 2008-07-31
WO2006078724A2 (en) 2006-07-27
CA2601380A1 (en) 2006-07-27
MX2007008662A (es) 2007-09-06

Similar Documents

Publication Publication Date Title
AU2022271425B2 (en) Processes of making and crystalline forms of a MDM2 inhibitor
EP3893871B1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
CN112566916B (zh) 作为pad4抑制剂的经取代的噻吩并吡咯
CA2860187C (en) Cyclic amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase and uses thereof
CN112300153B (zh) 一种杂环化合物、药物组合物和用途
EP3884939B1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
US8835633B2 (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
EA016199B1 (ru) Соединения и композиции как ингибиторы активирующей канал протеазы
AU2008250254A1 (en) New cyclic peptide compounds
CA3170664A1 (en) P2x3 modulators
CA2901770A1 (en) Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
TW202411219A (zh) 雜環化合物ccr4抑制劑及其用途
US7226906B2 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
US7553842B2 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
US20060035821A1 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
EP4634156A1 (en) Sarm1 modulators, preparations, and uses thereof
CN117447460A (zh) 作为ripk1抑制剂的杂环化合物
JP2010514732A (ja) 安定なs‐ニトロソチオール類、その合成方法および使用
EP0292923A2 (en) Piperidine compounds and pharmaceutical uses thereof
CN116143661B (zh) β-榄香烯不对称取代衍生物及其制备和用途
EP4219501A1 (en) Compound containing 2,4-thiazole ring, preparation method therefor, and application thereof
WO1999067239A1 (en) Pyrazolopyridine compounds and medicinal uses thereof
WO2024220874A2 (en) Otub1 small-molecule binders and otub1-recruiting deubiquitinase-targeting chimeras (dubtacs)
CN122003422A (zh) 杂环pad4抑制剂
HK40096020A (en) Mtorc1 modulators and uses thereof

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20 AUG 2007

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period